ロード中...
Prevention of skin carcinogenesis by the non-β-blocking R-carvedilol enantiomer
Skin cancer is the most common malignancy worldwide and is rapidly rising in incidence, representing a significant public health challenge. The β-blocker carvedilol has shown promising effects in preventing skin cancer. However, as a potent β-blocker, repurposing carvedilol to an anticancer agent is...
保存先:
| 出版年: | Cancer Prev Res (Phila) |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8102373/ https://ncbi.nlm.nih.gov/pubmed/33648941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-20-0609 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|